维他费林A通过多种机制抑制EBV驱动的淋巴发生,包括EBNA1降解
Jessica Stewart1, Blossom Damania2
1University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States.
Blood
|October 17, 2025
概括
维他费林A通过降解EBNA1并破坏病毒生存途径,选择性地准爱斯坦-巴尔病毒阳性淋巴瘤. 这种新的策略在临床前模型中显示出希望,为治疗这些侵略性的B细胞恶性瘤提供了一条新的途径.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 感染了全球90%以上的人口,导致像伯基特淋巴瘤和扩散性大B细胞淋巴瘤等侵袭性B细胞恶性瘤.
- 阳性EBV淋巴瘤往往对标准治疗的反应较差,原因是免疫逃避和细胞死亡途径的改变.
- 针对EBV特定的脆弱性,为这些具有挑战性的癌症提供了潜在的治疗策略.
研究的目的:
- 评估Withaferin A (WA) 对与EBV相关的B细胞非霍奇金淋巴瘤 (B-NHLs) 的疗效.
- 阐明WA发挥其抗淋巴瘤作用的机制.
- 在EBV驱动的淋巴发育的临床前模型中评估WA的治疗潜力.
主要方法:
- 淋巴瘤细胞系的查,以评估WA的细胞毒性.
- 涉及蛋白酶活性,EBV核抗原1 (EBNA1) 降解和细胞应激路径分析的机制研究.
- 使用初级B细胞模型和人性化的小鼠模型进行体内研究,以评估WA对淋巴发育和生存的影响.
主要成果:
- WA 显示对 EBV 阳性 B-NHLs 的选择性细胞毒性.
- WA诱导了EBNA1的蛋白质组依赖性降解,导致病毒病例的丧失.
- 在临床前模型中,WA破坏了抗氧化防御,增加了氧化应激,抑制了NF-κB信号传递,抑制了B细胞转化,减少了瘤负担,并在不增加病毒复制的情况下延长了生存时间.
结论:
- 维他费林A是一种强大的临床前候选药物,可以选择性地准EBV转型B细胞独特的脆弱性.
- WA的多方面机制破坏了病毒和宿主生存途径,提供了一种新的治疗方法.
- 对于EBV阳性B细胞恶性瘤,需要进一步优化和评估WA.
相关概念视频
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
01:29Immune Response Against Viral Pathogens
1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K